Sell Hims & Hers-OS VJ971X at $20 in Dec 2027 with a +101% gain / +€8,200 after 11 weeks to lock in profits.

You might want to hold onto the stock for now. Hims stock has risen 40% in 30 days because the company has reached a groundbreaking agreement with Novo Nordisk to sell Novo Nordisk’s highly sought-after GLP-1 weight-loss drugs, such as Wegovy and Ozempic, directly through its own platform. $HIMS (-1.22%)